Act. -0.15 Est. -0.29
Q1 2013 Alnylam Pharmaceuticals Earnings Conference Call
Call ended at 06 May 2013 05:52 PM
Act. -1.2 Est. -1.43
Q4 2012 Alnylam Pharmaceuticals Earnings Conference Call
Call ended at 07 Feb 2013 05:37 PMThe Medicines Company and Alnylam Pharmaceuticals, Inc Conference Call to Discuss Strategic Alliance to Develop and Commercialize RNAi Therapeutics Targeting PCSK9 for the Treatment of Hypercholesterolemia
Call ended at 04 Feb 2013 09:30 AMAlnylam Pharmaceuticals at Piper Jaffray Healthcare Conference
Call ended at 28 Nov 2012 11:28 AMAlnylam Pharmaceuticals Conference Call to Discuss Restructuring of Relationship with Tekmira
Call ended at 13 Nov 2012 08:26 AM
Act. -0.38 Est. -0.31
Q3 2012 Alnylam Pharmaceuticals Earnings Conference Call
Call ended at 05 Nov 2012 05:13 PMAlnylam Pharmaceuticals and Genzyme Discuss Alliance to Develop and Commercialize RNAi Therapeutics in Asia Conference Call
Call ended at 22 Oct 2012 08:28 AMAlnylam Pharmaceuticals at BioCentury and Thomson Reuters NewsMakers in the Biotech Industry
Call ended at 07 Sep 2012 02:56 PM
Act. -0.25 Est. -0.19
Q2 2012 Alnylam Pharmaceuticals Earnings Conference Call
Call ended at 06 Aug 2012 05:34 PMAlnylam Pharmaceuticals Conference Call To Discuss the clinical results from its ALN-TTR02 Phase I clinical trial
Call ended at 16 Jul 2012 09:18 AMAlnylam to Discuss Top-Line Results of Phase IIb Clinical Trial of ALN-RSV01, an Inhaled RNAi Therapeutic for the Treatment of Respiratory Syncytial Virus (RSV) Infection
Call ended at 30 May 2012 09:27 AM
Act. -0.25 Est. -0.36
Q1 2012 Alnylam Pharmaceuticals Earnings Conference Call
Call ended at 03 May 2012 05:19 PMAlnylam Pharmaceuticals at BioCentury & Thomson Reuters Future Leaders in the Biotech Industry: Clear Route Investment Conference
Call ended at 20 Apr 2012 10:32 AM
Previous
No events
Upcoming calls
Page 1 of 1
Showing 0 – 0 of 0 calls
Download
Embed
Share
